Details

Autor(en) / Beteiligte

• Munari, Stephanie C
• Wilkinson, Anna L
• Asselin, Jason
• Owen, Louise
• Read, Phillip
• Finlayson, Robert
• Martin, Sarah
• Bell, Charlotte
• O'Connor, Catherine C
• Carter, Allison
• Guy, Rebecca
• McNulty, Anna
• Varma, Rick
• Chow, Eric P F
• Fairley, Christopher K
• Donovan, Basil
• Stoove, Mark
• Goller, Jane L
• Hocking, Jane
• Hellard, Margaret E

Titel

Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018-2022

Ist Teil von

• Sexual health, 2024-02, Vol.21

Ort / Verlag

Australia

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Chlamydia remains the most notified bacterial sexually transmissible infection in Australia with guidelines recommending testing for re-infection at 3months post treatment. This paper aimed to determine chlamydia retesting and repeat positivity rates within 2-4months among young women in Australia, and to evaluate what factors increase or decrease the likelihood of retesting. Chlamydia retesting rates among 16-29-year-old women were analysed from Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of sexually transmissible infection and bloodborne virus (ACCESS) sentinel surveillance data (n =62 sites). Among women with at least one positive test between 1 January 2018 and 31 August 2022, retesting counts and proportions within 2-4months were calculated. Logistic regression was performed to assess factors associated with retesting within 2-4months. Among 8758 women who were positive before 31 August 2022 to allow time for follow up, 1423 (16.2%) were retested within 2-4months, of whom 179 (12.6%) tested positive. The odds of retesting within 2-4months were 25% lower if tested in a coronavirus disease 2019 (COVID-9) pandemic year (2020-2022) (aOR=0.75; 95% CI 0.59-0.95). Among 9140 women with a positive test before 30 November 2022, 397 (4.3%) were retested too early (within 7days to 1month) and 81 (20.4%) of those were positive. Chlamydia retesting rates remain low with around a sixth of women retested within 2-4months in line with guidelines. Re-infection is common with around one in eight retesting positive. An increase in retesting is required to reduce the risk of reproductive complications and onward transmission.